Lifechart is a technology company.
Lifechart has raised $700K across 2 funding rounds.
Lifechart has raised $700K in total across 2 funding rounds.
Lifechart has raised $700K in total across 2 funding rounds.
Lifechart's investors include Expert Dojo, Nitish Mittersain.
Lifechart is India's first gut health-tech Ayurveda brand, building a full-stack alternate healthcare ecosystem powered by AI to deliver instant, affordable, and accessible wellness solutions for masses in tier 2, 3, and 4 cities (Bharat).[1][3][4] It offers a mobile app connecting users to over 500 Ayurveda doctors (BAMS/BHMS) for 60-second consultations, personalized AI-driven predictions and diagnoses, clinically tested proprietary products like Stomach Care Granules and Acidity Care Syrup, and subscription-based care programs targeting gut issues such as constipation, acidity, fatty liver, and piles.[1][3][4] Serving primarily B2C customers with three revenue streams—consultations, private-label products, and Sanjeevani care programs—Lifechart has impacted over 250,000 users and raised $700K total funding, including a $500K seed round in 2024 to enhance AI, diagnostics, and tier 1 expansion.[3]
The platform solves underserved gut health problems by modernizing traditional Ayurveda with AI for scalability, prevention-focused wellness (including yoga, naturopathy, and mind counseling for chronic issues like diabetes, PCOS, anxiety), and holistic recovery from discovery to post-care.[1][2][3]
Lifechart was co-founded in 2022 by Mukul Shah and Mansi Sharma, with K. Sandeep as CTO and co-founder, emerging from a vision to bridge healthcare gaps in rural and tier 2/3 Indian cities by digitizing Ayurveda.[1][2][3] The idea stemmed from rising gut health issues and the need for preventive, root-cause wellness over symptom treatment, leveraging AI to make ancient practices like Ayurveda instant and personalized for Bharat's masses.[1][2][3] Early traction included a $200K pre-seed round in 2022 from Expert Dojo and Nazara Technologies' Nitish Mittersain, enabling app launch with 24/7 doctor access and product formulation; by 2024, a $500K seed from Prajay Advisors, Agility Ventures, Expert Dojo, and angels like Ahana Gautam propelled AI enhancements and 250,000+ users.[3]
Lifechart rides the gut health and wellness tech boom, tapping a global market projected at $18B by 2025-26 amid rising chronic issues like diabetes, PCOS, and digestive disorders in India.[3] Timing aligns with AI democratization in healthcare, post-COVID demand for preventive alternate medicine (Ayurveda via Ministry of Ayush), and digital penetration in tier 2+ cities where traditional access lags.[1][2][3] Favorable forces include government Ayurveda push, investor interest in healthtech (evident in its funding), and consumer shift to personalized, affordable digital wellness over allopathy.[1][3] It influences the ecosystem by pioneering AI-Ayurveda scalability, inspiring hybrid models, and expanding alternate care to rural India, potentially accelerating unicorn aspirations in India's $10B+ wellness sector.[2][3]
Lifechart's momentum—$500K seed, 250K users, AI diagnostics—positions it for tier 1 breakout and proprietary product launches, with metaverse gamification differentiating in engagement.[2][3] Trends like AI personalization, microbiome focus, and Web3 health incentives will propel growth toward its 2024 unicorn goal (ambitious but feasible in expanding markets).[2][3] Influence may evolve as a wellness super-app leader, blending Ayurveda with global tech to redefine preventive care. This gut health pioneer exemplifies how AI unlocks Bharat's wellness potential, transforming underserved lives one consultation at a time.[1][2][3]
Lifechart has raised $700K across 2 funding rounds. Most recently, it raised $500K Seed in October 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2024 | $500K Seed | Expert Dojo, Nitish Mittersain | |
| May 1, 2022 | $200K Seed | Expert Dojo, Nitish Mittersain |